Atlas Venture , a leading biotech venture capital firm,today announced the launch of Generation Bio , a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit. Atlas founded the company in 2016 with a $25 million Series A.
Generation Bio is developing a breakthrough class of genetic medicines based on its proprietary GeneWave technology, which delivers high levels of durable gene expression and can be re-dosed to titrate and sus...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
